Obese
225
14
24
153
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
31 trials with published results (14%)
Research Maturity
153 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
7 terminated out of 225 trials
95.6%
+9.0% vs benchmark
7%
16 trials in Phase 3/4
20%
31 of 153 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 153 completed trials
Clinical Trials (225)
Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome
A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults
The Expecting Study
Longitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A Prospective Observational Study
Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss
Exercise Response in Humans With Obesity
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
Mechanical Ventilation in Obese Surgical Patients
A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Trans-nasal Endoscopy for Bariatric Patients
Influence of Changes in Food Group Variety on Food Cravings, Energy Intake, and Weight Loss After Bariatric Surgery
Effect of Combined Resisted Training and Protein-based Diet on Frailty in Sarcopenic Elderly Women
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
A Study of LY3502970 in Healthy Overweight and Obese Participants
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants